Omada Health, Inc. Common Stock (OMDA)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ
Market Cap: $889.00M
Last updated: Nov 17, 2026 at 11:05 AM ET
Omada Health, Inc. Common Stock (OMDA) P/E Ratio & Valuation Multiples
Omada Health, Inc. Common Stock (OMDA) trades at 36.6x trailing earnings and 2.6x sales. Its forward P/E is 43.5x. The median P/E across 7 similar companies is 35.0x.
Current Multiples
Its forward P/E is above its trailing P/E, which implies earnings per share about 15.9% lower over the next year. Its free cash flow yield is 2.6%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 36.6x |
| Forward P/E | 43.5x |
| Price to sales | 2.6x |
| Price to book | 3.2x |
| Price to FCF | 39.2x |
|---|---|
| EV/FCF | 28.4x |
| PEG | N/A |
| FCF yield | 2.6% |
As of Nov 17, 2026
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About OMDA
What is OMDA's forward P/E ratio?
Omada Health, Inc. Common Stock has a forward P/E ratio of 43.5x.
Is OMDA stock overvalued?
GNG's valuation label for OMDA is Undervalued. Its P/E of 36.6x compares with a median of 35.0x across 7 similar companies.
What is OMDA's price to sales ratio?
Omada Health, Inc. Common Stock has a price to sales ratio of 2.6x.
OMDA pages: Overview, Forecast, Financials, Valuation, Competitors